Loading clinical trials...
Loading clinical trials...
An Open-label, Multi-center, Phase I/II Study of MFA-370 in Patients with Metastatic Urothelial Cancer
Conditions
Interventions
MFA-370
Locations
1
Sweden
Karolinska University Hospital
Stockholm, Sweden
Start Date
December 1, 2024
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
September 26, 2024
NCT05101096
NCT06505746
NCT02091999
NCT03451331
NCT03679767
Lead Sponsor
Ectin Research AB
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions